Exercise limitation in chronic obstructive pulmonary disease

Current Respiratory Medicine Reviews

Volumn 4, Issue 4, 2008, Pages 258-269

  Laveneziana, Pierantonio ^a   Wadell, Karin ^a   Webb, Katherine ^a   O'Donnell, Denis E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

COPD; Dynamic hyperinflation; Dyspnea; Energy metabolism; Exercise; Muscle dysfunction; Ventilatory mechanics

Indexed keywords

BREATHING MECHANICS; CARDIOPULMONARY FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EXERCISE; EXPIRATORY FLOW; HEART DISEASE; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LEG DISEASE; LUNG VENTILATION; MUSCLE DISEASE; PATHOPHYSIOLOGY; PHYSICAL CAPACITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKELETAL MUSCLE;

EID: 65949114426     PISSN: 1573398X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339808786263752     Document Type: Review

References (115)

1. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709-21.
2. Johnson BD, Badr MS, Dempsey JA. Impact of the aging pulmonary system on the response to exercise. In: Weisman IM, Zeballos RJ, Eds. Clinics in Chest Medicine, Philadelphia, WB: Saunders. 1994; 15: 229-46.
3. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J 2006; 28: 1245-57.
4. O'Donnell DE, Webb KA. Exercise. In: Calverley PMA, MacNee W, Pride NB, Rennard SI, eds. Chronic Obstructive Pulmonary Disease, 2nd ed. London: Arnold, 2003; Chapter 18: pp. 243-69.
5. O'Donnell DE, Revill S, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 770-7.
6. Ofir D, Laveneziana P, Webb KA, Lam YM, O'Donnell DE. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: 622-9.
7. Barbera JA, Roca J, Ramirez J, Wagner PD, Usetti P, Rodriquez-Roisin R. Gas exchange during exercise in mild chronic obstructive pulmonary disease: correlation with lung structure. Am Rev Respir Dis 1991; 144: 520-5.
8. Dantzker DR, D'Alonzo GE. The effect of exercise on pulmonary gas exchange in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 134: 1135-9.
9. Dillard TA, Piantadosi S, Rajagopal KR. Prediction of ventilation at maximal exercise in chronic airflow obstruction. Am Rev Respir Dis 1985; 132: 230-5.
10. O'Donnell DE, McGuire M, Samis L, Webb KA. Effects of general exercise training on ventilatory and peripheral muscle strength and endurance in chronic airflow limitation. Am J Respir Crit Care Med 1998; 157: 1489-97.
11. O'Donnell DE, Webb KA. Breathlessness in patients with severe chronic airflow limitation: Physiological correlates. Chest 1992; 102: 824-31.
12. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71: 1033-47.
13. Gayan-Ramirez G, Koulouris N, Roca J, Decramer M. Respiratory and skeletal muscles in chronic obstructive pulmonary disease. Eur Respir Mon 2006; 38: 201-23.
14. Hyatt RE. Expiratory flow limitation. J Appl Physiol 1983; 55: 1-8.
15. Pride NB, Macklem PT. Lung mechanics in disease. In: Fishman AP, Ed, Handbook of Physiology, Section 3, Vol III, Part 2: The Respiratory System. Bethesda, MD: American Physiological Society 1986; 659-92.
16. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006; 3: 219-32.
17. O'Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006; 15: 61-7.
18. Aliverti A, Stevenson N, Dellacà RL, Lo Mauro A, Pedotti A, Calverley PMA. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 2004; 59: 210-6.
19. Vogiatzis I, Georgiadou O, Golemati S, et al. Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease. Thorax 2005; 60: 723-9.
20. Stubbing DG, Pengelly LD, Morse JLC, Jones NL. Pulmonary mechanics during exercise in subjects with chronic airflow obstruction. J Appl Physiol 1980; 49: 511-5.
21. O'Donnell D, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-40.
22. Sinderby C, Spahija J, Beck J, et al. Diaphragm activation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1637-41.
23. Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983; 55: 8-15.
24. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 55-9.
25. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: 109-15.
26. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1557-65.
27. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over eight hours with once-daily tiotropium in patients with COPD. Chest 2005; 128: 1168-78.
28. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1395-9.
29. Babb TG, Viggiano R, Hurley B, Staats B, Rodarte JR. Effect of mild-to-moderate airflow limitation on exercise capacity. J Appl Physiol 1991; 70: 223-30.
30. O'Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol 2006; 101: 1025-35.
31. Similowski T, Yan S, Gauthier AP, Macklem PT, Bellemare F. Contractile properties of the human diaphragm during chronic hyperinflation. N Engl J Med 1991; 325: 917-23.
32. Bye PT, Esau SA, Levy RD,Levy RD, et al. Ventilatory muscle functions during exercise in air and oxygen in patients with chronic airflow limitation. Am Rev Respir Dis 1985; 132: 236-40.
33. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphgram in chronic obstructive pulmonary disease. N Engl J Med 1997; 337: 1799-806.
34. Mador MJ, Kufel TJ, Pineda LA, Sharma GK. Diaphragmatic fatigue and high-intensity exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 118-23.
35. Orozco-Levi M, Gea J, Lloreta JL, et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 371-8.
36. O'Donnell DE, D'Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med 2002; 166: 663-8.
37. Matthay RA, Berger HJ, Davies RA, et al. Right and left ventricular exercise performance in chronic obstructive pulmonary disease: radionuclide assessment. Ann Intern Med 1980; 93: 234-9.
38. Gilbert R, Keighley J, Auchincloss JH. Disability in patients with obstructive pulmonary disease. Am Rev Respir Dis 1964; 90: 383-94.
39. Wolkove N, Dajczman E, Colacone A, Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest 1989; 96: 1247-51.
40. Hay JG, Stone P, Carter J, et al. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992; 5: 659-64.
41. Bauerle O, Chrusch CA, Younes M. Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998; 157: 57-68.
42. Carlson DJ, Ries AL, Kaplan RM. Predictors of maximum exercise tolerance in patients with COPD. Chest 1991; 100: 307-11.
43. Diaz O, Villafranca C, Ghezzo H, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J 2000; 16: 269-75.
44. Puente-Maestu L, de Pedro GJ, Martinez-Abad Y, de Ona RJM, Llorente D, Cubillo JM. Dyspnea, ventilatory pattern, and changes in dynamic hyperinflation related to the intensity of constant work rate exercise in COPD. Chest 2005; 128: 651-6.
45. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-40.
46. Palange P, Forte S, Onorati P, Manfredi F, Serra P, Carlone S. Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 2000; 88: 1715-20.
47. Mathur RS, Revill SM, Vara DD, Walton R, Morgan MD. Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax 1995; 50: 829-33.
48. Man WD, Soliman MG, Gearing J, et al. Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 562-7.
49. O'Donnell DE, Webb KA. Mechanisms of dyspnea in COPD. In: Mahler DA, O'Donnell DE, Eds. Dyspnea: Mechanisms, Measurement, and Management, 2nd edition. Lung Biology in Health and Disease Series, Boca Raton, FL: Taylor & Francis Group 2005; 208(Chap 3): 29-58.
50. O'Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007; 4: 145-68.
51. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation: the role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-7.
52. Leblanc P, Bowie DM, Summers E, Jones NL, Killian KJ. Breathlessness and exercise in patients with cardiorespiratory disease. Am Rev Respir Dis 1986; 133: 21-5.
53. Chen Z, Eldridge FL, Wagner PG. Respiratory-associated thalamic activity is related to level of respiratory drive. Respir Physiol 1992; 90: 99-113.
54. Gandevia SC. The perception of motor commands on effort during muscular paralysis. Brain 1982; 105: 151-95.
55. Hill L, Flack F. The effect of excess of carbon dioxide and of want of oxygen upon the respiration and the circulation. J Physiol 1908; 37: 77-111.
56. Fowler WS. Breaking point of breath-holding. J Appl Physiol 1954; 6: 539-45.
57. Whitelaw WA, McBride B, Amar J, Corbet K. Respiratory neuromuscular output during breath holding. J Appl Physiol 1981; 50: 435-43.
58. Schwartzstein RM, Simon PM, Weiss JW, Fencl V, Weinberger SE. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis 1989; 39: 1231-7.
59. O'Donnell DE, Hong HH, Webb KA. Respiratory sensation during chest wall restriction and dead space loading in exercising men. J Appl Physiol 2000; 88: 1859-69.
60. Campbell EJ, Howell JB. The sensation of breathlessness. Br Med Bull 1963; 19: 36-40.
61. Zechman FR Jr, Wiley RI. Afferent inputs to breathing: respiratory sensation: In: Fishman AP, Ed. Handbook of physiology. The respiratory system. Bethesda MD: American Physiological Society 1986; II(Sec 3, Part 2): 449-74.
62. Laghi F, Jurban A, Topeli A, et al. Effect of lung volume reduction surgery on neuromechanical coupling of the diaphragm. Am J Respir Crit Care Med 1998; 157: 475-83.
63. Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Resp Dis 1982; 126: 166-70.
64. Magee F, Wright JL, Wiggs BR, Pare PD, Hogg JC. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax 1988; 43: 183-9.
65. Agusti AGN, Barbera JA, Roca J, Wagner PD, Guitart R, Rodriguez-Roisin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest 1990; 97: 268-75.
66. Light RW, Mintz WM, Linden GS, Brown SE. Hemodynamics of patients with severe chronic obstructive pulmonary disease during progressive upright exercise. Am Rev Respir Dis 1984; 130: 391-5.
67. Mahler DA, Brent BN, Loke J, Zaret BL, Matthay RA. Right ventricular performance and central hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 130: 722-9.
68. Oswald-Mammosser M, Apprill M, Bachez P, Ehrhart M, Weitzenblum E. Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type. Respiration 1991; 58: 304-10.
69. Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE. Hemodinamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002; 166: 314-22.
70. Vizza CD, Lynch JP, Ochoa LL, Richardson G, Trulock EP. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113: 576-83.
71. Morrison DA, Adock K, Collins CM, Goldman S, Caldwell JH, Schwartz MI. Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease. J Am Coll Cardiol 1987; 9: 1219-29.
72. Potter WA, Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease. J Clin Invest 1971; 50: 910-9.
73. Kayser B, Sliwinski P, Yan S, Tobias M, Macklem PT. Respiratory effort sensation during exercise with induced expiratory flow limitation in healthy humans. J Appl Physiol 1997; 83: 936-47.
74. Iandelli I, Aliverti A, Kayser B, et al. Determinants of exercise performance in normal men with externally applied expiratory flow limitation. J Appl Physiol 2002; 92:1943-52.
75. Aliverti A, Iandelli I, Duranti R, et al. Respiratory muscle dynamics and control during exercise with externally applied expiratory flow limitation. J Appl Physiol 2002; 92: 1953-63.
76. Aliverti A, Dellaca' RL, Lotti P, et al. Influence of expiratory flow-limitation during exercise on systemic oxygen delivery in humans. Eur J Appl Physiol 2005; 95: 229-42.
77. Stark-Leyva KN, Beck KC, Johnson BD: Influence of expiratory loading and hyperinflation on cardiac output during exercise. J Appl Physiol 2004; 96: 1920-7.
78. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-31.
79. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153(3): 976-80.
80. ATS/ERS. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159:S1-40.
81. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21(2): 347-60.
82. Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy? Respirology 2006; 11(6): 681-6.
83. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 2002; 19(4): 617-25.
84. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990; 3(2): 192-6.
85. Maltais F, Sullivan MJ, LeBlanc P, et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 1999; 13(4): 850-4.
86. Satta A, Migliori GB, Spanevello A, et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10(12): 2853-60.
87. Whittom F, Jobin J, Simard PM, et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998; 30(10): 1467-74.
88. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:374-7.
89. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153(1): 288-93.
90. Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax 2002; 57(12): 1067-70.
91. Couillard A, Maltais F, Saey D, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167(12): 1664-9.
92. Jobin J, Maltais F, Doyon JF, et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil 1998; 18(6): 432-7.
93. Maltais F, Jobin J, Sullivan MJ, et al. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol 1998; 84(5): 1573-80.
94. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143(1): 9-18.
95. Wuyam B, Payen JF, Levy P, et al. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J 1992; 5(2): 157-62.
96. Debigare R, Marquis K, Cote CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003; 124(1): 83-9.
97. Sala E, Roca J, Marrades RM, et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159(6): 1726-34.
98. Kamischke A, Kemper DE, Castel MA, et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11(1): 41-5.
99. Vermereen MP, Creutzberg EC, Schols AM, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respire Med 2006; 100: 1349-55.
100. Gosselink R, Troosters T, Decramer M. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2000; 20(6): 353-60.
101. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(2): 629-34.
102. van't Hul A, Harlaar J, Gosselink R, Hollander P, Postmus P, Kwakkel G. Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease. Muscle Nerve 2004; 29(2): 267-74.
103. Gosker HR, Lencer NH, Franssen FM, van der Vusse GJ, Wouters EF, Schols AM. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003; 123(5): 1416-24.
104. Janaudis-Ferreira T, Wadell K, Sundelin G, Lindstrom B. Thigh muscle strength and endurance in patients with COPD compared with healthy controls. Respir Med 2006; 100(8): 1451-7.
105. Mador MJ, Deniz O, Aggarwal A, Kufel TJ. Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168(1): 102-8.
106. Franssen FM, Wouters EF, Baarends EM, Akkermans MA, Schols AM. Arm mechanical efficiency and arm exercise capacity are relatively preserved in chronic obstructive pulmonary disease. Med Sci Sports Exerc 2002; 34(10): 1570-6.
107. Degens H, Sanches Horneros JM, Heijdra YF, Dekhuijzen PN, Hopman ME. Skeletal muscle contractility is preserved in COPD patients with normal fat-free mass. Acta Physiol Scand 2005; 184: 235-42.
108. Sherrington CS. The muscular sense. In: Shafer SA, Ed. Textbook of Physiology. Edingburgh: TJ Pentland 1900; 2: 1002-25.
109. Matthews PBC. Where does Sherrington's 'muscular sense' originate: muscles, joints, corollary discharge? Ann Rev Neurosci 1982; 5: 189-218.
110. Jeffery Mador M, Kufel TJ, Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 447-53.
111. Saey D, Debigare R, LeBlanc P, et al. Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168(4): 425-30.
112. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reduction in exercise lactic acidosis and ventilation as a result of exercise training in obstructive lung disease. Am Rev Respir Dis 1991; 143: 9-18.
113. O'Donnell DE, Bain DJ, Webb KA. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med 1997; 155: 530-5.
114. O'Donnell DE, D'Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 892-8.
115. Amann M, Romer LM, Pegelow DF, Jacques AJ, Hess CJ, Dempsey JA. Effects of arterial oxygen content on peripheral locomotor muscle fatigue. J Appl Physiol 2006; 101(1): 119-27.